Olivier DapremontExecutive Director, Technology and Innovation at SK pharmtecoSpeaker
Profile
Dr Dapremont has over 30 years of experience in continuous processes for pharmaceuticals. He started his career in equipment manufacturing before moving into CDMO business. After 25 years of spearheading the R&D engineering team at AFC, he moved to the technology and Innovation group at SK Pharmteco corporation in California.
He is a recognized expert in the development of large-scale chiral separations using Simulated Moving Bed (SMB). He is the author of several articles and chapters in reference books. He is co-inventor on patents for API purification and equipment development. He is an active member of the ACS Green Chemistry.
Agenda Sessions
Addressing the Acetonitrile Supply by Implementing Recovery and Reuse Strategies
, 1:15pmView Session
